|
FAM45A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.52899999999701E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.037600E-04 |
| Normal-vs-Stage2 |
8.159400E-04 |
| Normal-vs-Stage3 |
1.037660E-03 |
| Normal-vs-Stage4 |
2.849600E-04 |
| Stage1-vs-Stage2 |
5.476800E-01 |
| Stage1-vs-Stage3 |
9.844200E-01 |
| Stage1-vs-Stage4 |
5.864800E-01 |
| Stage2-vs-Stage3 |
5.857200E-01 |
| Stage2-vs-Stage4 |
9.439000E-01 |
| Stage3-vs-Stage4 |
6.130400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.177250E-04 |
| Normal-vs-AfricanAmerican |
2.897400E-01 |
| Normal-vs-Asian |
1.00540000003146E-06 |
| Caucasian-vs-AfricanAmerican |
1.237420E-01 |
| Caucasian-vs-Asian |
2.954400E-02 |
| AfricanAmerican-vs-Asian |
1.629820E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.236900E-03 |
| Normal-vs-Female |
3.81649999999789E-05 |
| Male-vs-Female |
5.312200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.028600E-04 |
| Normal-vs-Age(41-60Yrs) |
1.156180E-04 |
| Normal-vs-Age(61-80Yrs) |
6.196800E-03 |
| Normal-vs-Age(81-100Yrs) |
3.537500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.373000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.244600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.662200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.865800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.247800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.744030E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.795800E-01 |
| Classical-VS-Follicular |
9.270400E-01 |
| Classical-VS-Other |
8.266400E-01 |
| Classical-VS-Normal |
1.432980E-04 |
| Tall-VS-Follicular |
9.648800E-01 |
| Tall-VS-Other |
8.365000E-01 |
| Tall-VS-Normal |
7.896500E-03 |
| Follicular-VS-Other |
8.108400E-01 |
| Follicular-VS-Normal |
4.297600E-03 |
| Other-VS-Normal |
4.714600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.584780E-04 |
| Normal-vs-N1 |
2.710600000011E-07 |
| N0-vs-N1 |
3.047600E-02 |
|
|
